EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
26 hedge funds and large institutions have $9.94M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Holders
26
Holding in Top 10
2
Calls
$35K
Puts
–
Top Buyers
| 1 | +$1.69M | |
| 2 | +$1.65M | |
| 3 | +$93.1K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.4K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$8.69K |
Top Sellers
| 1 | -$118K | |
| 2 | -$26.9K | |
| 3 | -$24.4K | |
| 4 |
Two Sigma Investments
New York
|
-$16.5K |
| 5 |
Millennium Management
New York
|
-$9K |